Reliance Pharma Fund(G)

158.99 -2.76 (-1.71%) NAV as on 24-Sep-18
52-Week High ( ) 165.89 (07-Sep-18)
52-Week Low ( ) 127.03 (27-Sep-17)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 2619.71
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return20.4020.261.0821.32
Category Avg0.85-6.02-5.0710.70
Category Best6.111.76-0.8320.87
Category Worst-4.12-13.46-7.57-6.29
SENSEX11.1813.8112.04-
BSE HC16.4910.14-3.68-
NIFTY9.7010.0711.70-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries LimitedDomestic Equities10.47
Divi's Laboratories LimitedDomestic Equities8.34
Dr. Reddy's Laboratories LimitedDomestic Equities8.16
Aurobindo Pharma LimitedDomestic Equities7.75
Cipla LimitedDomestic Equities7.59
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 25/09/2018 As on 25/09/2018

11067.45 (0.91) 36652.06 (0.96)

TOP GAINERS

Company Price Change Gain (%)
Pochiraju Industries3.350.5519.64
Nagarjuna Oil1.550.2519.23

TOP LOSERS

Company Price Change Loss (%)
MPS Infotecnics0.05-0.05-50.00
KSS0.15-0.05-25.00

Portfolio Comparison

MUTUAL FUND ACTIVITY